HeartSciences (HSCS) Total Liabilities (2021 - 2026)

HeartSciences has reported Total Liabilities for 6 years, with the latest figure at $4.9 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 25.15% year-over-year to $4.9 million; the trailing twelve-month figure through Jan 2026 stood at $4.9 million (up 25.15% YoY), and the FY2025 full-year result was $4.0 million, up 83.81% from the prior year.
• Total Liabilities for Q1 2026 stood at $4.9 million, up from $1.8 million in the prior quarter.
• The five-year high for Total Liabilities was $8.1 million in Q2 2022, with the low at $1.8 million in Q4 2025.
• Historically, Total Liabilities has averaged $3.6 million across 5 years, with a median of $3.7 million in 2022.
• Annual changes were most pronounced in 2023 — Total Liabilities slumped 62.47% — and 2025, when it surged 83.81%.
• HeartSciences' Total Liabilities stood at $3.7 million in 2022, then increased by 8.95% to $4.0 million in 2023, then fell by 6.41% to $3.8 million in 2024, then slumped by 51.77% to $1.8 million in 2025, then surged by 170.31% to $4.9 million in 2026.
• The last three Total Liabilities figures came in at $4.9 million (Q1 2026), $1.8 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.